Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Covington
US Department of Justice
Daiichi Sankyo
Healthtrust
Julphar
Merck
Fuji
Argus Health

Generated: April 25, 2018

DrugPatentWatch Database Preview

Oxytetracycline calcium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxytetracycline calcium and what is the scope of oxytetracycline calcium patent protection?

Oxytetracycline calcium
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for oxytetracycline calcium.
Synonyms for oxytetracycline calcium
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4AR,5S,5AR,6S,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4-(DIMETHYLAMINO)-5,6,10,11,12A-PENTAHYDROXY-6-METHYL-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4s,4ar,5s,5ar,6s,12as)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide
102287-29-6
103351-03-7
105145-10-6
106216-57-3
1135442-00-0
135740-EP2275422A1
135740-EP2292608A1
1405-95-4
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4-alpha,4a-alpha,5-alpha,5a-alpha,6-beta,12a-alpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-
2058-46-0
2058-46-0 (mono-hydrochloride)
21645-09-0
4-14-00-02633 (Beilstein Handbook Reference)
5-Hydroxy-Tetracycline
5-Hydroxytetracycline
52214-46-7
6153-64-6 (di-hydrate)
6153-65-7 (di-hydrochloride salt, di-hydrate)
64038-91-1 (sulfate (2:1))
69766-62-7 (hydrochloride salt)
7179-50-2 (calcium (1:1) salt)
79-57-2
79-57-2 (ANHYDROUS)
856305-69-6
96310-42-8
AB00053514_04
AB00053514_05
AB01274728_02
AB01274728-01
AB1009358
AB1009512
AC-12777
AC-13466
AC1L1MWD
AC1NQXTY
AC1NQZMP
Adamycin
AKOS015951277
AKOS015961254
AN-23998
Antibiotic TM 25
API0003726
BC202856
BDBM241973
Berkmycen
BIB6305
Biostat
Biostat PA
BPBio1_000302
BRN 2714587
BSPBio_000274
BSPBio_002151
C06624
C22H24N2O9
CAS-79-57-2
CHEBI:27701
CHEMBL1401333
CHEMBL1517
CHEMBL461529
CS-2265
CTK6H8882
Dabicycline
Dalimycin
DB00595
DivK1c_000225
DSSTox_CID_14260
DSSTox_GSID_34260
DSSTox_RID_79133
DTXSID1034260
E703
EBD2197445
EINECS 201-212-8
Embryostat
Fanterrin
FT-0603288
Galsenomycin
Geomycin
Geomycin (Streptomyces rimosus)
Geomycin (Streptomyces vimosus)
Geotilin
HSDB 3145
HY-B0275
Hydroxytetracycline
Hydroxytetracyclinum
IDI1_000225
Imperacin
IWVCMVBTMGNXQD-PXOLEDIWSA-N
KBio1_000225
KBio2_001535
KBio2_004103
KBio2_006671
KBio3_001651
KBioGR_000912
KBioSS_001535
LA 200
Lenocycline
Liquamycin LA 200
LMPK07000005
LS-93860
Macocyn
MCULE-5398230579
Medamycin
Mepatar
MLS000069429
MolPort-002-524-946
MolPort-005-934-326
Mycoshield TMQTHC 20
NCGC00091268-04
NCGC00091268-05
NCGC00091268-06
NCGC00091268-07
NCGC00091268-08
NCGC00091268-09
NCGC00091268-11
NCGC00091268-12
NCGC00188956-01
NCGC00255168-01
NCI-C56473
NINDS_000225
NSC-9169
NSC9169 (HCL)
OGYE Selective Supplement; Oxytetracycline
Oksisyklin
Opera_ID_661
Ossitetraciclina
Ossitetraciclina [DCIT]
OTC
OTC (antibiotic)
OWFJMIVZYSDULZ-PXOLEDIWSA-N
Oxacycline
Oxitetraciclina
Oxitetraciclina [INN-Spanish]
Oxitetracyclin
Oxitetracycline
Oxitetracyclinum
Oxy-Kesso-tetra
Oxydon
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetra Selective Supplement, for microbiology
Oxytetracid
Oxytetracyclin
oxytetracycline
Oxytetracycline (anhydrous)
Oxytetracycline (internal use)
Oxytetracycline (Terramycin)
Oxytetracycline [INN]
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline base
Oxytetracycline HCl
Oxytetracycline, European Pharmacopoeia (EP) Reference Standard
Oxytetracyclinum
Oxytetracyclinum [INN-Latin]
Pennox 200
PL039846
PL070081
Prestwick0_000307
Prestwick1_000307
Prestwick2_000307
Prestwick3_000307
Proteroxyna
Riomitsin
Ryomycin
s1773
S470
SBI-0051473.P003
SCHEMBL13169109
SCHEMBL13782651
SCHEMBL2899
SCHEMBL560497
SLF0D9077S
SMR000059000
Solkaciclina
SPBio_001055
SPBio_002493
Spectrum_001055
Spectrum2_000988
Spectrum3_000536
Spectrum4_000466
Spectrum5_001148
ST50307307
Stecsolin
Stevacin
STOCK1N-50853
Tarocyn
Tarosin
Teravit
Terrafungine
Terramicina Oftalmica
Terramitsin
Terramycin
Terramycin im
Terramycin Q50
Tetracycline, 5-hydroxy-
Tetran
TM 5
Tox21_302380
UNII-SLF0D9077S
Unimycin
Ursocyclin
Ursocycline
Vendarcin
ZINC100026355
ZINC100303028
ZINC95626782

US Patents and Regulatory Information for oxytetracycline calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TERRAMYCIN oxytetracycline calcium SYRUP;ORAL 060595-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Harvard Business School
Chubb
Covington
Julphar
Medtronic
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.